# Decoy Therapeutics Inc.: filings

DCOY · Nasdaq · CIK 1615219 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/dcoy.md) · [Financials](/companies/dcoy/financials.md) · [Filings](/companies/dcoy/filings.md) · [Insiders](/companies/dcoy/insiders.md)

## Reports and events: 272 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 233, 8-K 166, 10-Q 35, 3 34, CORRESP 26, 425 20, UPLOAD 17, DEF 14A 16, 424B5 14, DEFA14A 13, EFFECT 13, 10-K 12, SC 13G/A 12, 4/A 11, S-1/A 11, SC 13G 11, S-8 9, SC 13D 8, 8-K/A 7, S-1 7, S-3 7, 424B3 6, SC 13D/A 6, PRE 14A 5, 3/A 4, CT ORDER 4, D 4, FWP 4, SCHEDULE 13G 4, 10-K/A 3, 424B4 3, 5 2, S-1MEF 2, S-3/A 2, S-4/A 2, 10-Q/A 1, 8-A12B 1, CERTNAS 1, DFAN14A 1, DRS 1, DRS/A 1, DRSLTR 1, RW 1, S-4 1, SCHEDULE 13G/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-07 | 20:59 ET | [S-1](/filings/0001193125-26-417053.md) | Registration statement | 0001193125-26-417053 |
| 2026-09-23 | 21:02 ET | [8-K](/filings/0001615219-26-000019.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001615219-26-000019 |
| 2026-09-15 | 21:00 ET | [8-K](/filings/0001615219-26-000016.md) | 5.07 Shareholder vote results | 0001615219-26-000016 |
| 2026-08-12 | 20:09 ET | [10-Q](/filings/0001193125-26-346852.md) | Quarterly report, period 2026-06-30 | 0001193125-26-346852 |
| 2026-08-04 | 20:59 ET | [DEF 14A](/filings/0001193125-26-332762.md) | Proxy statement, period 2026-09-14 | 0001193125-26-332762 |
| 2026-07-15 | 21:14 ET | [8-K](/filings/0001193125-26-304949.md) | 5.07 Shareholder vote results | 0001193125-26-304949 |
| 2026-07-10 | 20:26 ET | [S-1](/filings/0001193125-26-300954.md) | Registration statement | 0001193125-26-300954 |
| 2026-06-29 | 10:03 ET | [8-K](/filings/0001193125-26-286737.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-286737 |
| 2026-06-15 | 22:54 ET | [S-1](/filings/0001193125-26-269891.md) | Registration statement | 0001193125-26-269891 |
| 2026-06-04 | 12:26 ET | [DEF 14A](/filings/0001193125-26-256541.md) | Proxy statement, period 2026-06-04 | 0001193125-26-256541 |
| 2026-05-19 | 20:06 ET | [8-K](/filings/0001193125-26-230749.md) | 5.08 Item not in the standard list; 8.01 Other events | 0001193125-26-230749 |
| 2026-05-08 | 20:45 ET | [10-Q](/filings/0001193125-26-214816.md) | Quarterly report, period 2026-03-31 | 0001193125-26-214816 |
| 2026-04-30 | 17:03 ET | [10-K/A](/filings/0001193125-26-195909.md) | Annual report, amended, period 2025-12-31 | 0001193125-26-195909 |
| 2026-04-02 | 13:05 ET | [8-K](/filings/0001193125-26-139145.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-139145 |
| 2026-03-31 | 21:05 ET | [10-K](/filings/0001193125-26-134897.md) | Annual report, period 2025-12-31 | 0001193125-26-134897 |
| 2026-03-05 | 14:21 ET | [8-K](/filings/0001193125-26-092748.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-092748 |
| 2026-02-25 | 14:15 ET | [8-K](/filings/0001193125-26-068813.md) | 5.07 Shareholder vote results | 0001193125-26-068813 |
| 2026-01-09 | 22:08 ET | [DEF 14A](/filings/0001193125-26-008944.md) | Proxy statement, period 2026-02-24 | 0001193125-26-008944 |
| 2026-01-08 | 17:38 ET | [8-K](/filings/0001615219-26-000013.md) | 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001615219-26-000013 |
| 2026-01-02 | 22:14 ET | [8-K](/filings/0001615219-26-000005.md) | 3.01 Delisting notice | 0001615219-26-000005 |
| 2026-01-02 | 22:13 ET | [8-K](/filings/0001615219-26-000003.md) | 5.07 Shareholder vote results | 0001615219-26-000003 |
| 2025-12-19 | 21:31 ET | [8-K](/filings/0001615219-25-000197.md) | 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001615219-25-000197 |
| 2025-11-19 | 21:05 ET | [8-K](/filings/0001615219-25-000168.md) | 5.02 Departure or appointment of officers or directors | 0001615219-25-000168 |
| 2025-11-17 | 22:23 ET | [8-K](/filings/0001615219-25-000166.md) | 7.01 Regulation FD disclosure | 0001615219-25-000166 |
| 2025-11-14 | 22:23 ET | [10-Q](/filings/0001615219-25-000164.md) | Quarterly report, period 2025-09-30 | 0001615219-25-000164 |
| 2025-11-13 | 21:08 ET | [8-K](/filings/0001615219-25-000162.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001615219-25-000162 |
| 2025-11-07 | 19:16 ET | [DEF 14A](/filings/0001615219-25-000152.md) | Proxy statement, period 2024-12-31 | 0001615219-25-000152 |
| 2025-10-21 | 16:09 ET | [S-1/A](/filings/0001628280-25-045619.md) | Registration statement, amended | 0001628280-25-045619 |
| 2025-10-21 | 15:57 ET | [8-K](/filings/0001615219-25-000148.md) | 5.02 Departure or appointment of officers or directors | 0001615219-25-000148 |
| 2025-10-14 | 12:00 ET | [8-K](/filings/0001615219-25-000145.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001615219-25-000145 |
| 2025-10-06 | 20:12 ET | [8-K](/filings/0001615219-25-000142.md) | 8.01 Other events | 0001615219-25-000142 |
| 2025-09-23 | 21:27 ET | [S-1/A](/filings/0001628280-25-042500.md) | Registration statement, amended | 0001628280-25-042500 |
| 2025-09-18 | 11:01 ET | [8-K](/filings/0001615219-25-000135.md) | 1.01 Entry into a material agreement; 3.03 Change to security holders’ rights; 9.01 Financial statements and exhibits | 0001615219-25-000135 |
| 2025-09-09 | 12:04 ET | [8-K](/filings/0001615219-25-000125.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001615219-25-000125 |
| 2025-08-27 | 20:10 ET | [8-K](/filings/0001615219-25-000119.md) | 8.01 Other events | 0001615219-25-000119 |
| 2025-08-26 | 21:29 ET | [8-K](/filings/0001615219-25-000117.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001615219-25-000117 |
| 2025-08-26 | 20:07 ET | [8-K/A](/filings/0001615219-25-000115.md) | 9.01 Financial statements and exhibits | 0001615219-25-000115 |
| 2025-08-22 | 21:14 ET | [8-K](/filings/0001628280-25-041043.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-25-041043 |
| 2025-08-18 | 12:33 ET | [8-K](/filings/0001615219-25-000107.md) | 5.02 Departure or appointment of officers or directors | 0001615219-25-000107 |
| 2025-08-15 | 15:03 ET | [8-K](/filings/0001615219-25-000101.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001615219-25-000101 |
| 2025-08-12 | 21:27 ET | [10-Q](/filings/0001615219-25-000096.md) | Quarterly report, period 2025-06-30 | 0001615219-25-000096 |
| 2025-08-08 | 00:50 ET | [S-1/A](/filings/0001628280-25-039090.md) | Registration statement, amended | 0001628280-25-039090 |
| 2025-07-31 | 21:02 ET | [8-K](/filings/0001615219-25-000080.md) | 2.02 Results of operations; 3.02 Unregistered sale of equity | 0001615219-25-000080 |
| 2025-07-31 | 15:08 ET | [S-1/A](/filings/0001628280-25-036892.md) | Registration statement, amended | 0001628280-25-036892 |
| 2025-07-29 | 20:54 ET | [8-K](/filings/0001615219-25-000078.md) | 1.01 Entry into a material agreement; 3.03 Change to security holders’ rights; 9.01 Financial statements and exhibits | 0001615219-25-000078 |
| 2025-07-28 | 21:05 ET | [8-K](/filings/0001615219-25-000076.md) | 8.01 Other events | 0001615219-25-000076 |
| 2025-07-21 | 12:39 ET | [8-K](/filings/0001615219-25-000072.md) | 1.01 Entry into a material agreement; 3.03 Change to security holders’ rights; 9.01 Financial statements and exhibits | 0001615219-25-000072 |
| 2025-07-14 | 12:33 ET | [8-K](/filings/0001615219-25-000069.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001615219-25-000069 |
| 2025-07-08 | 16:00 ET | [8-K](/filings/0001615219-25-000066.md) | 5.07 Shareholder vote results | 0001615219-25-000066 |
| 2025-06-16 | 21:01 ET | [S-1/A](/filings/0001628280-25-031631.md) | Registration statement, amended | 0001628280-25-031631 |

Page 1 of 6. [Older](/companies/dcoy/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:14 ET. No prices; not investment advice.